| abstract |
Provided is a medicament for treating bipolar disorder, in particular bipolar disorder type I and type II, in particular bipolar disorder type I. Agomelatine, ie, N- [2- (7-methoxy-1-naphthyl) ethyl] acetamide, or a hydrate, a crystalline form thereof, and an addition salt with a pharmaceutically acceptable acid or a base thereof. A pharmaceutical composition comprising alone or in combination with one or more pharmaceutically acceptable excipients, further in combination with an emotion modifier such as lithium, valproate, etc. Also good. [Selection figure] None |